))
A Sensible Approach to LDT Regulation
Manage episode 439388950 series 3599669
Indhold leveret af ARUP Laboratories. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af ARUP Laboratories eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
The VALID Act currently being debated in Congress would increase the regulatory burden on clinical laboratories. In this interview, Dr. David Grenache from TriCore Laboratories and the University of New Mexico, together with Dr. Vince Stine from the American Association for Clinical Chemistry, explain why VALID would slow down innovation while it raises costs, and why VALID appears to be designed to benefit a particular industry sector rather than patients.
86 episoder
Del
